BRPI0109674B1 - Método de concentração e de recuperação de uma atividade de enzima de vírus envelopados presentes em uma amostra biológica, e, embalagem comercial - Google Patents

Método de concentração e de recuperação de uma atividade de enzima de vírus envelopados presentes em uma amostra biológica, e, embalagem comercial

Info

Publication number
BRPI0109674B1
BRPI0109674B1 BRPI0109674-5B1A BRPI0109674A BRPI0109674B1 BR PI0109674 B1 BRPI0109674 B1 BR PI0109674B1 BR PI0109674 A BRPI0109674 A BR PI0109674A BR PI0109674 B1 BRPI0109674 B1 BR PI0109674B1
Authority
BR
Brazil
Prior art keywords
enzyme activity
biological sample
buffer solution
enveloped viruses
matrix
Prior art date
Application number
BRPI0109674-5B1A
Other languages
English (en)
Inventor
Anders Malmsten
Clas Kaellander
Ingvar Pettersson
Simon Gronowitz
Tommy Gatu
Original Assignee
Cavidi Tech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cavidi Tech Ab filed Critical Cavidi Tech Ab
Publication of BRPI0109674A publication Critical patent/BRPI0109674A/pt
Publication of BRPI0109674B1 publication Critical patent/BRPI0109674B1/pt
Publication of BRPI0109674B8 publication Critical patent/BRPI0109674B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/91245—Nucleotidyltransferases (2.7.7)
    • G01N2333/9125—Nucleotidyltransferases (2.7.7) with a definite EC number (2.7.7.-)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BRPI0109674 2000-03-29 2001-03-22 Método de concentração e de recuperação de uma atividade de enzima de vírus envelopados presentes em uma amostra biológica, e, embalagem comercial BRPI0109674B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0001132A SE0001132D0 (sv) 2000-03-29 2000-03-29 Method of concentrating and recovering a viral enzyme activity from biological samples
PCT/SE2001/000617 WO2001075147A1 (en) 2000-03-29 2001-03-22 Method of concentrating and recovering a viral enzyme activity from biological samples

Publications (3)

Publication Number Publication Date
BRPI0109674A BRPI0109674A (pt) 2003-02-04
BRPI0109674B1 true BRPI0109674B1 (pt) 2014-02-11
BRPI0109674B8 BRPI0109674B8 (pt) 2021-07-06

Family

ID=20279073

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0109674 BRPI0109674B8 (pt) 2000-03-29 2001-03-22 Método de concentração e de recuperação de uma atividade de enzima de vírus envelopados presentes em uma amostra biológica, e, embalagem comercial

Country Status (12)

Country Link
US (1) US7833700B2 (pt)
EP (1) EP1268851B1 (pt)
CN (1) CN1204265C (pt)
AT (1) ATE307897T1 (pt)
AU (1) AU2001244921A1 (pt)
BR (1) BRPI0109674B8 (pt)
DE (1) DE60114389T2 (pt)
DK (1) DK1268851T3 (pt)
ES (1) ES2252206T3 (pt)
HK (1) HK1053855B (pt)
SE (1) SE0001132D0 (pt)
WO (1) WO2001075147A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0101219D0 (sv) 2001-04-05 2001-04-05 Cavidi Tech Ab Recovery of enzyme activity from enveloped viruses
OA12620A (en) * 2001-06-14 2006-06-12 Cavidi Tech Ab Viral drug susceptibility testing.
DE10230819B4 (de) * 2002-07-08 2007-12-06 Kronotec Ag Fussbodenpaneel
AU2003298594A1 (en) 2002-11-01 2004-06-07 Promega Corporation Cell lysis compositions, methods of use, apparatus, and kit

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482834A (en) * 1982-05-17 1996-01-09 Hahnemann University Evaluation of nucleic acids in a biological sample hybridization in a solution of chaotrophic salt solubilized cells
US4707439A (en) 1984-10-26 1987-11-17 The United States Of America As Represented By The Department Of Health And Human Services Screening test for reverse-transcriptase containing virus such as non-A, non-B hepatitis, NANBH
JPH06507078A (ja) * 1992-02-10 1994-08-11 バクスター、インターナショナル、インコーポレイテッド ウイルス汚染について血液単位を試験するための方法
US5658779A (en) * 1992-03-20 1997-08-19 Ligochem, Inc. Method of adsorbing viruses from fluid compositions
AU2127395A (en) * 1994-03-22 1995-10-09 Rhone-Poulenc Rorer Pharmaceuticals Inc. Highly efficient production and isolation of viral particles
SE9902410D0 (sv) * 1999-06-24 1999-06-24 Cavidi Tech Ab Reverse transcriptase assay kit, use thereof and method for analysis of RT activity in biological samples

Also Published As

Publication number Publication date
EP1268851A1 (en) 2003-01-02
AU2001244921A1 (en) 2001-10-15
SE0001132D0 (sv) 2000-03-29
HK1053855B (zh) 2006-09-01
US20030104441A1 (en) 2003-06-05
ATE307897T1 (de) 2005-11-15
BRPI0109674A (pt) 2003-02-04
EP1268851B1 (en) 2005-10-26
DE60114389T2 (de) 2006-07-13
DE60114389D1 (de) 2005-12-01
CN1204265C (zh) 2005-06-01
ES2252206T3 (es) 2006-05-16
CN1419605A (zh) 2003-05-21
WO2001075147A1 (en) 2001-10-11
BRPI0109674B8 (pt) 2021-07-06
US7833700B2 (en) 2010-11-16
HK1053855A1 (en) 2003-11-07
DK1268851T3 (da) 2006-03-13

Similar Documents

Publication Publication Date Title
Azem et al. The protein-folding activity of chaperonins correlates with the symmetric GroEL14 (GroES7) 2 heterooligomer.
Ward Mechanism of poliovirus inactivation by ammonia
DE69836587D1 (de) Nukleinsäuresammlung
US10308929B2 (en) Method of preparing biological material
NO980881L (no) Fremgangsmater og blandinger for selektiv modifikasjon av nukleinsyrer
Herrler et al. A synthetic sialic acid analogue is recognized by influenza C virus as a receptor determinant but is resistant to the receptor-destroying enzyme.
BRPI0109674B1 (pt) Método de concentração e de recuperação de uma atividade de enzima de vírus envelopados presentes em uma amostra biológica, e, embalagem comercial
JP3108105B2 (ja) 共沈剤及び核酸の抽出方法
SE0101219D0 (sv) Recovery of enzyme activity from enveloped viruses
Boulanger et al. The role of surface sialic acid in adenovirus-cell adsorption
WO2011113043A2 (en) Sample storage for molecular and immunological detection
Holland et al. Application of serological and DNA methods for the identification of urine specimen donors
RU2624241C1 (ru) Твердофазный носитель для иммобилизации и/или хранения биологических образцов, содержащих нуклеиновые кислоты
CN102888390B (zh) 肝素酶ⅲ的固定化方法
AP1592A (en) Viral drug susceptibility testing
Banerjee Characterization of an adenosine triphosphatase from myeloblasts infected with the avian myeloblastosis virus
CN115404233A (zh) 一种核酸提取试剂及其使用方法
Hormozi Jangi Naked-Eye Sensing of SARS-CoV-2 Utilizing Nanozymatic Nanoassays
Oakey et al. A comparison of biospecific affinity chromatographic methodologies for the purification of NAD+-dependent dehydrogenases: studies with bovine l-lactate dehydrogenase
Plavsic Evaluation of Two Bovine Cell Lines as Hosts for Detecting Several Common Bovine Viruses in Fetal Bovine Serum
Yamagata et al. Immobilization of Saccharomyces cerevisiae cystathionine γ-lyase and application of the product to cystathionine synthesis
Guber et al. The effect of aging resolved chromatophores of Rhodospirillum rubrum on the capacity to reconstitute the energy-linked transhydrogenation
Lei et al. Immobilized Enzymes in Nanoporous Materials Exhibit Enhanced Stability and Activity
Caliò et al. On the Nature of the Hemolytic Activity of Sendai Virus: A Kinetic Study
Tuma et al. Development of a Reverse-Transcription PCR (RT-PCR) for the Detection of HIV-1 RNA in Single Blood Donations